Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards

Recognition given for achievement in commercializing Joenja® , a first-in-class medication brought to market 10 years after disease state, APDS, was first characterized Leiden, the Netherlands,...

Related Keywords

London ,City Of ,United Kingdom ,Australia ,Amsterdam ,Noord Holland ,Netherlands ,Japan ,Canada ,United States ,Americans ,America ,Michael Levitan ,Christina Renfroe ,Peter Saltonstall ,Stephen Toor ,Linkedin ,Exchange Commission ,Nasdaq ,National Organization For Rare Disorders ,Pharming Groupnv ,Lifespring Life Sciences Communication ,Drug Administration ,Vp Investor Relations Corporate Communications ,Pharming Group ,Industry Innovator ,National Organization ,Rare Disorders ,Rare Impact Awards ,Chief Commercial Officer ,Activated Phosphoinositide ,North America ,Middle East ,Annual Report ,Allergy Clin ,Rev Allergy ,Clinical Immunology ,Spring Life Sciences Communication ,Markets ,